trastuzumab emtansine Articles
US FDA approves Roche's late-stage breast cancer drug Kadcyla
25 February 2013
Growing patient population to drive Mexican breast cancer market
20 February 2013
Roche affiliate Chugai files for T-DM1 approval in Japan; gains rights to Afraxis compound
30 January 2013
More highlights from ESMO Congress
2 October 2012
Genentech's T-DM1 significantly improved survival for metastatic breast cancer patients
29 August 2012
Showing 1-7 of 7 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
